Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Smoldering Multiple Myeloma in Latin America- Risk Stratification

Blood (2024) 144 (Supplement 1): 3774.

https://doi.org/10.1182/blood-2024-209038

Published: 2024

Journal Articles

Meter: A Multi-Country, Real-World Chart Review Study to Explore Treatment Patterns, Effectiveness and Healthcare Resource Utilization for Patients with Myelofibrosis

Vikas Gupta, Ciprian Tomuleasa, Gilberto Israel Barranco Lampon, Hsin-An Hou, Grzegorz Helbig, Argiris S. Symeonidis, Ibrahim Haznedaroglu, Kenny Galvez, Fernando Tatsch, Avijeet S Chopra, Meng Zhang, Tamas Vizkelety, David M Ross

Blood (2023) 142 (Supplement 1): 3205.

https://doi.org/10.1182/blood-2023-173942

Published: 2023

Journal Articles

Clinical Features and Prognostic Factors in Multiple Myeloma Patients from Colombia. Real-World Data from Renehoc Registry

Blood (2023) 142 (Supplement 1): 6636.

https://doi.org/10.1182/blood-2023-181336

Published: 2023

Journal Articles

Freedo mm : A Multicenter Observational Study of Multiple Myeloma in Second Relapse in Colombia

Guillermo Quintero, Sandra Aruachan, Jair Figueroa Emiliani, Kenny Galvez, Luis Antonio Salazar, Melissa Diaz, Diana Camila Buitrago, Humberto Martinez-Cordero, Juliana Saavedra

Blood (2023) 142 (Supplement 1): 6654.

https://doi.org/10.1182/blood-2023-190068

Published: 2023

Journal Articles

Demographic and Clinical Characteristics of Multiple Myeloma Patients in Latin America

Vania T.M. Hungria, Damila Trufelli, Jaqueline Saes, Karina Nakajima, Lays Leonel, Rafael Gaiolla, Kenny Galvez, Guillermina Remaggi, Rosane Bittencourt, Angelo Maiolino, Natalia Paola Schutz, Guillermo Quintero

Blood (2022) 140 (Supplement 1): 12487–12489.

https://doi.org/10.1182/blood-2022-163763

Published: 2022

Journal Articles

Outcomes after First Rescue Treatment in Patients with Relapsed or Refractory Multiple Myeloma in Colombia

Blood (2021) 138 (Supplement 1): 4745.

https://doi.org/10.1182/blood-2021-154190

Published: 2021

Journal Articles

Multiple Myeloma Mortality Incidence Prevalence of Disease - Mmy Mind Study

Humberto Martínez Cordero, MD, Jessica Zapata Malagon, Lorena Cubillos Osorio, Alejandro Rico Mendoza, Alexandra Porras Ramírez, Juan Ospina Idarraga, Henry Idrobo, MD, Viviana Olaya, Kenny Galvez, MD, Sergio Cancelado, MD, Juan Manuel Herrera, MD, Leonardo Bautista Toloza, MD

Blood (2020) 136 (Supplement 1): 10–11.

https://doi.org/10.1182/blood-2020-142376

Published: 2020

Journal Articles

Multiple Myeloma Multicenter Registry in Colombia: The Impact of Autologous Stem Transplantation on Overall and Disease-Free Survival

Virginia Abello, MD, Claudia Lucia Sossa, Henry Idrobo, MD, Guillermo Quintero, MD, William Mantilla, MD, Kenny Galvez, MD, Alicia Henao-Uribe, MD, Rigoberto Gomez, MD, Domingo Saavedra, MD, Lina Gaviria, MD, Jheremy Enrique Reyes Castellanos, Monica Osuna Pérez, MD, Juan Manuel Herrera, MD

Blood (2020) 136 (Supplement 1): 47–48.

https://doi.org/10.1182/blood-2020-139747

Published: 2020

Journal Articles

Closing the Efficacy and Effectiveness Gap: Outcomes in Relapsed/Refractory Multiple Myeloma (RRMM) Patients (Pts) Treated with Ixazomib-Lenalidomide-Dexamethasone (IRd) in Routine Clinical Practice Remain Comparable to the Outcomes Reported in the Phase 3 Tourmaline-MM1 Study

Roman Hajek, Prof, MD PhD, Jiri Minarik, MD PhD, Jan Straub, MD, Ludek Pour, MD, Alexandra Jungova, Jesus G. Berdeja, MD, Mario Boccadoro, Lucie Brožová, MSc, Andrew Spencer, MBBS, FRACP, FRCPA, DM, Frits van Rhee, MD PhD, Jorge Vela-Ojeda, MD PhD, Michael A. Thompson, MD PhD FASCO, Rafat Abonour, MD, Ajai Chari, MD, Gordon Cook, MB ChB, PhD FRCP(Glas), FRCPath, Caitlin L. Costello, MD, Faith E. Davies, MD, Vania T.M. Hungria, MD PhD, Hans C. Lee, MD, Xavier Leleu, MD PhD, Noemi Puig, MD PhD, Robert M. Rifkin, MD, Evangelos Terpos, MD PhD, Saad Z. Usmani, MD FACP, Katja C. Weisel, MD, Jeffrey A. Zonder, Magda Bařinová, MSc, Matyáš Kuhn, MSc, Jiri Silar, MSc, Lenka Capkova, Kenny Galvez, MD, Jin Lu, MDProf, Tomas Skacel, MD, Jennifer Elliott, Brittany Demers, BS, BA, Dawn Marie Stull, Pharm.D., BCOP, Kaili Ren, PhD, Vladimir Maisnar, MD PhD MBA

Blood (2019) 134 (Supplement_1): 1845.

https://doi.org/10.1182/blood-2019-126606

Published: 2019

Journal Articles

Unequal Outcomes in Transplant Eligible Patients with Multiple Myeloma in Latin America: Differences between Public and Private Centers

Camila Peña, MD, Natalia Paola Schutz, MDMSc, Virginia Bove, MD, Fiorella Villano, MD, Rocío Osorio, MD, Mauricio Chandia, MD, Cecilia Beltran, MD, Javier Schulz, MD, Daniela Cardemil, MD, Carolina Contreras, MD, Carmen Gloria Vergara, MD, Javiera Donoso, MD, Marcela Espinoza, MD, Gabriel La Rocca, MD, Hernán López-Vidal, MD, Pilar León, MD, Christine Rojas, MD, Pablo Soto, MD, Sandra Aranda, MD, Vivianne Torres, MD, Paola Ochoa, MD, Patricio Duarte, MD, Guillermina Remaggi, MD, Sebastian Yantorno, MD, Ariel Corzo, MD, Soledad Zabaljauregui, MD, Claudia Shanley, MD, Sergio Lopresti, MD, Sergio Orlando, MD, Veronica Verri, MD, Luis Darío Quiroga, MD, Carlos García, MD, Vanesa Fernandez, MD, Dorotea Fantl, MD, Jhoanna Ramirez, MD, Alicia Molina, MD, Pilar Papilco, MD, Alex Mite, MD, Ines Reyes, MD, Brener Sabando, MD, Francisca M. Ramirez Aspiazu, MD, Claudia Lucia Sossa, MD, Virginia Abello, MD, Henry Idrobo, MD Professor, Kenny Galvez, MD, Domingo Saavedra, MD, Guillermo Quintero, MD MBA, Raimundo Gazitua, MD, Lina Gaviria, MD, Rigoberto Gomez, MD, Monica Osuna Pérez, MD, Alicia Henao-Uribe, MD, Luz del Carmen Tarín Arzaga, MD, Omar Cantú-Martínez, MD, David Gomez-Almaguer, MD, Yarely Itzayana García-Navarrete, MD, Antonio Cruz-Mora, MD, Yahveth Cantero-Fortiz, MD, Guillermo J. Ruiz-Arguelles, FRCP, MACP, Macarena Roa, MD, Eloisa Riva, MD

Blood (2019) 134 (Supplement_1): 5497.

https://doi.org/10.1182/blood-2019-127555

Published: 2019

NARROW

Smoldering Multiple Myeloma in Latin America- Risk Stratification

Meter: A Multi-Country, Real-World Chart Review Study to Explore Treatment Patterns, Effectiveness and Healthcare Resource Utilization for Patients with Myelofibrosis

Clinical Features and Prognostic Factors in Multiple Myeloma Patients from Colombia. Real-World Data from Renehoc Registry

Freedo mm : A Multicenter Observational Study of Multiple Myeloma in Second Relapse in Colombia

Demographic and Clinical Characteristics of Multiple Myeloma Patients in Latin America

Outcomes after First Rescue Treatment in Patients with Relapsed or Refractory Multiple Myeloma in Colombia

Multiple Myeloma Mortality Incidence Prevalence of Disease - Mmy Mind Study

Multiple Myeloma Multicenter Registry in Colombia: The Impact of Autologous Stem Transplantation on Overall and Disease-Free Survival

Closing the Efficacy and Effectiveness Gap: Outcomes in Relapsed/Refractory Multiple Myeloma (RRMM) Patients (Pts) Treated with Ixazomib-Lenalidomide-Dexamethasone (IRd) in Routine Clinical Practice Remain Comparable to the Outcomes Reported in the Phase 3 Tourmaline-MM1 Study

Unequal Outcomes in Transplant Eligible Patients with Multiple Myeloma in Latin America: Differences between Public and Private Centers

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only